Mary Hayden to Mupirocin
This is a "connection" page, showing publications Mary Hayden has written about Mupirocin.
Connection Strength
1.211
-
Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial. J Clin Microbiol. 2016 11; 54(11):2735-2742.
Score: 0.582
-
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
Score: 0.238
-
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650.
Score: 0.173
-
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother. 2013 Jan; 57(1):552-8.
Score: 0.112
-
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet. 2019 Mar 23; 393(10177):1205-1215.
Score: 0.043
-
Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2016 Jan; 16(1):70-79.
Score: 0.035
-
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013 Jun 13; 368(24):2255-65.
Score: 0.029